Live Webinar
Wednesday, August 26, 2020
7-8:15 pm ET
Currently few anesthesiologists and pain physicians initiate buprenorphine in patients suffering from opioid use disorder (OUD). Initiating buprenorphine in this period has the potential to save lives. Anesthesiologists and pain physicians frequently encounter patients with comorbid OUD, thus are uniquely positioned to act. Proving an overview of buprenorphine and specific guidance on its use during the perioperative, postoperative, and clinic setting will be valuable in preventing morbidity and mortality related to OUD.
Topics include
- Pharmacological overview
- Buprenorphine in the perioperative setting
- Buprenorphine in the outpatient setting
- Buprenorphine in the treatment of chronic pain
$25 ASRA members; $50 for nonmembers (eligible for 1.25 CME credits)
$10 Trainees (no CME)
Registration for this event is closed.